Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection

Over the past two decades, ribavirin has been an integral component of treatment for hepatitis C virus (HCV) infection, where it has been shown to improve the efficacy of (pegylated) interferon. However, because of treatment‐limiting side effects and its additive toxicity with interferon, the search...

Descripción completa

Detalles Bibliográficos
Autores principales: Feld, Jordan J., Jacobson, Ira M., Sulkowski, Mark S., Poordad, Fred, Tatsch, Fernando, Pawlotsky, Jean‐Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216450/
https://www.ncbi.nlm.nih.gov/pubmed/27473533
http://dx.doi.org/10.1111/liv.13212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216450/
https://www.ncbi.nlm.nih.gov/pubmed/27473533
http://dx.doi.org/10.1111/liv.13212

Ejemplares similares